Neurodegenerative disease biomarkers Aβ1–40, Aβ1–42, tau, and p‐tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy. Issue 2 (13th January 2018)
- Record Type:
- Journal Article
- Title:
- Neurodegenerative disease biomarkers Aβ1–40, Aβ1–42, tau, and p‐tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy. Issue 2 (13th January 2018)
- Main Title:
- Neurodegenerative disease biomarkers Aβ1–40, Aβ1–42, tau, and p‐tau181 in the vervet monkey cerebrospinal fluid: Relation to normal aging, genetic influences, and cerebral amyloid angiopathy
- Authors:
- Chen, Jason A.
Fears, Scott C.
Jasinska, Anna J.
Huang, Alden
Al‐Sharif, Noor B.
Scheibel, Kevin E.
Dyer, Thomas D.
Fagan, Anne M.
Blangero, John
Woods, Roger
Jorgensen, Matthew J.
Kaplan, Jay R.
Freimer, Nelson B.
Coppola, Giovanni - Abstract:
- Abstract: Background: The Caribbean vervet monkey ( Chlorocebus aethiops sabaeus ) is a potentially valuable animal model of neurodegenerative disease. However, the trajectory of aging in vervets and its relationship to human disease is incompletely understood. Methods: To characterize biomarkers associated with neurodegeneration, we measured cerebrospinal fluid (CSF) concentrations of Aβ1–40, Aβ1–42, total tau, and p‐tau181 in 329 members of a multigenerational pedigree. Linkage and genome‐wide association were used to elucidate a genetic contribution to these traits. Results: Aβ1–40 concentrations were significantly correlated with age, brain total surface area, and gray matter thickness. Levels of p‐tau181 were associated with cerebral volume and brain total surface area. Among the measured analytes, only CSF Aβ1–40 was heritable. No significant linkage (LOD > 3.3) was found, though suggestive linkage was highlighted on chromosomes 4 and 12. Genome‐wide association identified a suggestive locus near the chromosome 4 linkage peak. Conclusions: Overall, these results support the vervet as a non‐human primate model of amyloid‐related neurodegeneration, such as Alzheimer's disease and cerebral amyloid angiopathy, and highlight Aβ1–40 and p‐tau181 as potentially valuable biomarkers of these processes. Abstract : The Caribbean vervet monkey (Chlorocebus aethiops sabaeus) is a potentially valuable animal model of neurodegenerative disease. We identified correlations with agingAbstract: Background: The Caribbean vervet monkey ( Chlorocebus aethiops sabaeus ) is a potentially valuable animal model of neurodegenerative disease. However, the trajectory of aging in vervets and its relationship to human disease is incompletely understood. Methods: To characterize biomarkers associated with neurodegeneration, we measured cerebrospinal fluid (CSF) concentrations of Aβ1–40, Aβ1–42, total tau, and p‐tau181 in 329 members of a multigenerational pedigree. Linkage and genome‐wide association were used to elucidate a genetic contribution to these traits. Results: Aβ1–40 concentrations were significantly correlated with age, brain total surface area, and gray matter thickness. Levels of p‐tau181 were associated with cerebral volume and brain total surface area. Among the measured analytes, only CSF Aβ1–40 was heritable. No significant linkage (LOD > 3.3) was found, though suggestive linkage was highlighted on chromosomes 4 and 12. Genome‐wide association identified a suggestive locus near the chromosome 4 linkage peak. Conclusions: Overall, these results support the vervet as a non‐human primate model of amyloid‐related neurodegeneration, such as Alzheimer's disease and cerebral amyloid angiopathy, and highlight Aβ1–40 and p‐tau181 as potentially valuable biomarkers of these processes. Abstract : The Caribbean vervet monkey (Chlorocebus aethiops sabaeus) is a potentially valuable animal model of neurodegenerative disease. We identified correlations with aging and brain atrophy with Aβ1–40 and p‐tau181 in a vervet pedigree and further identified heritability in these measurements, pointing towards applicability of the vervet model. … (more)
- Is Part Of:
- Brain and behavior. Volume 8:Issue 2(2018)
- Journal:
- Brain and behavior
- Issue:
- Volume 8:Issue 2(2018)
- Issue Display:
- Volume 8, Issue 2 (2018)
- Year:
- 2018
- Volume:
- 8
- Issue:
- 2
- Issue Sort Value:
- 2018-0008-0002-0000
- Page Start:
- n/a
- Page End:
- n/a
- Publication Date:
- 2018-01-13
- Subjects:
- Alzheimer's disease -- amyloid beta -- cerebral amyloid angiopathy -- cerebrospinal fluid -- tau -- vervet
Neurology -- Periodicals
Neurosciences -- Periodicals
Psychology -- Periodicals
Psychiatry -- Periodicals
616.8005 - Journal URLs:
- http://bibpurl.oclc.org/web/52745 \u http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2157-9032 ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2157-9032 ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/1650 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/brb3.903 ↗
- Languages:
- English
- ISSNs:
- 2162-3279
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5885.xml